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ABSTRACT
Proper regulation of the acclaimed functionality and safety of the health food is a consensus among the health authorities of every nation. The
objective of this study is focused on the methods development for safety and functionality of hepatic injury prevention of health food using CCl4induced hepatotoxicity as model. The result from this study could provide some useful information for setting a feasible and reasonable evaluating
method for regulatory purpose. In this study, we have shown that in the untreated rats, administration of CCl4 at 0.05 and 0.20 mL/ kg, BW caused the
increase of SGOT activities from 118 ± 25 to 328 ± 42 and 670 ± 95 (U/L), respectively; SGPT activities from 48 ± 5 to 170 ± 18 and 535 ± 123 (U/L),
respectively. In the rats treated with silymarin for 7 days at 140 mg/ kg, BW prior the administration of CCl4 could attenuate the liver injury induced by
CCl4 at 0.05 and 0.20 mL/ kg, BW. Similar results were obtained when pretreated with Ganoderma lucidum and red ginseng. However, none of the pretreatment can effectively prevent or reduce the liver injury induced by CCl4 at higher dosage (0.40 and 0.80 mL/ kg, BW). In addition, we have also
found that no toxic effects were observed when pretreated with silymarin, Ganoderma lucidum and red ginseng for 7 and 30 days as judged by the
pathological examination and serum enzyme activities. The results of this study might provide some useful information for the Department of Health
with a scientific and objective means to evaluate the safety and functionality for the hepatic injury prevention of health foods.
Key words: silymarin, Ganoderma lucidum, red ginseng extract, functionality, safety, hepatotoxicity

INTRODUCTION
Foods possessing health-promoting functions are
becoming popular around the world and have received
great attention by the health authorities of most countries
as people are becoming aware of their health enhancement. However, lack of medical knowledge by the public, untruthful sales, and exaggerated propaganda have
made the health food market chaotic. As a result, health
food quality varies greatly. In such circumstances, not
only is the function for health promotion not guaranteed,
but also, in some cases, it even jeopardizes health (1-7).
According to statistical data from the Department of
Health, hepatic-related diseases, such as chronic hepatic
disease, liver cirrhosis, and liver cancer rank in the top
ten for causing deaths in Taiwan. Therefore, most of the
commercially available health-promoting foods are likely to emphasize their ability to prevent hepatic injury.
Health foods have been integrated into our lives. Thus, to
develop a method to evaluate the safety and functionality of hepatic injury prevention by health foods in order to
assist the health authorities to promote people’s health is
necessary and needs to be done quickly.
Some chemicals such as ethanol (8-10), carbon tetrachloride (CCl 4 ) (11) , and acetaminophen (12) , have been
reported to cause hepatotoxicity. Carbon tetrachloride is
capable of causing liver necrosis, changing the activities
of metabolic enzymes in liver(13), as well as increasing
the hepatic lipid peroxidation(14). It has been shown that
* Author for correspondence. Tel: 02-27361661 ext. 686;
Fax: 02-23775875.

the hazardous factor for inducing liver disease could
affect the mode of action of the hepatic metabolic
enzyme and increase the hepatic lipid peroxidation,
resulting in fatty liver, liver cirrhosis, and liver necrosis.
Therefore, CCl 4 was used as a liver damage-inducing
agent in this study to evaluate the hepato-protection
property of some selected health foods.
Ganoderma lucidum and ginseng have been claimed by
traditional health food practitioners as being able to improve
health, enhance strength, and prevent tumors. Some literatures have reported that Ganoderma lucidum exhibits the
ability to prevent tumors(15), inhibit histamine-release(16),
decrease cholesterol synthesis(17), and protect against hepatorelated diseases(18,19). Ginseng has been shown to carry the
liver-protection activity via a cytochrom P450 inhibition to
reduce CCl 4 -induced hepatic lipid peroxidation (20,21) .
However, a valid method to evaluate the functionality of
health food has not yet been established. To take the CCl4induced hepatotoxicity study as an example, a single medication was usually used to test for the performance on reduction
of CCl 4-induced hepatotoxicity. Determination of CCl 4
dosage and induction time was dependent on the experimental design. In this study, the CCl4 dosage was tested and optimized to evaluate the hepato-protection functionality of
health food. The results of this study could provide a scientific and objective method to evaluate the functionality of
hepato-prevention by health foods and could be useful information for related authorities in establishing health food
related regulations.

MATERIALS AND METHODS
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I. Materials
Carbon tetrachloride (of purity >99.5%) was obtained
from Merck (F. R. Germany). Corn oil was purchased from
Sigma (St. Louis, MO, USA) and silymarin (70 mg/capsule)
was purchased from N. V. Sanico. Ganoderma lucidum
(mycelium, 500 mg/capsule) was obtained from Sheng
Foong Pharmaceutical Co., Ltd. Red ginseng concentrate
(1g) extracted from 2g red ginseng was purchased from
Korea T. & Ginseng Corp.
II. Methods
(I) Treatment of Animals
Male Wistar rats (100-120 g) purchased from the animal
center at the medical school at National Taiwan University
were randomly divided into 3 groups with 5 animals in each
group. The experimental group was administrated with
Ganoderma lucidum and ginseng, the positive control group
was administrated with silymarin, and the normal control
group was administrated with water. Before administration,
rats were acclimated in an animal feeding center for one
week. During acclimation and experimentation, an animalfeeding standard of water and food (from Purina Mills, Inc.,
St. Louis, MO) and light exposure was strictly followed. Rats
in the experimental group were administrated with 10 mL of
Ganoderma lucidum (500 mg/kg) solution or 10 mL of red
ginseng (1g/kg) solution. Rats in the positive control and normal control groups were administrated with 10 mL of silymarin (140 mg/kg) solution and water, respectively. The
administration was conducted by gavage once a day for 7
consecutive days followed by treatment with CCl4. The activities of the following hepatic enzymes were measured as biochemical parameters of liver functionality: glutamic
oxaloacetic transaminase (SGOT), glutamic pyruvic
transaminase (SGPT), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH). After 7 and 30 consecutive days
of administration of the drug, the body, liver, kidney weights,
and SGOT, SGPT, ALP, LDH, and blood urea nitrogen
(BUN) were measured to investigate the toxic effect of
repeated drug treatment on the animals.
(II) Method for Inducing Acute Liver Injury by CCl4
Four dosages, 0.05, 0.20, 0.40, and 0.80 mL/kg, of CCl4
in 5 mL of corn oil were tested to induce acute liver injury in
rats. The experimental group was intraperitoneally treated
with CCl4 while the vehicle control group received only corn
oil. Rats were then sacrificed after 24 hr and blood from the
peritoneal artery was collected.
(III) Clinical Biochemistry Test
After drug treatment, the rats were anesthetized with
diethyl ether, and blood (~8 mL) from the peritoneal artery
was collected and transferred to a test tube containing STT

gel, which is for separating serum from blood cells and preventing hematolysis. Blood in the test tube was left to stand
until coagulation and then centrifuged at 2500 rpm (CR5B2
Hitachi, Ltd., Tokyo, Japan) for 12 min. The upper layer was
collected and tested for serum biochemistry using an automatic analyzer (Model 7450, Hitachi, Ltd., Tokyo, Japan).
(IV) Statistical Analysis
The unpair Student’s t-test (P<0.05) was used to compare the differences of CCl4- and corn oil-induced serum biochemical parameters concurrent with silymarin, Ganoderma
lucidum, red ginseng concentrate, or water administration.
The CCl4-induced serum biochemical parameters in experiment and control groups were also compared.

RESULTS
I. The Toxic Effect on Animal as Repeating Treatment with
Drug
After oral administration with silymarin, Ganoderma
lucidum, or red ginseng concentrate for 7 and 30 days, the
rats were sacrificed via a peritoneal artery bloodletting. The
blood was then tested for serum enzyme activities and the
weights of livers and kidneys were measured. A statistical
study showed that there was no significant difference in
body, liver, and kidney weights, nor on serum enzyme activities including SGOT, SGPT, ALP, LDH, and BUN (Table 1).
II. Effect of Silymarin on Hepatotoxicity Induced by Different
Dosage of CCl4
After administration with silymarin for 7 days, rats were
then treated with four dosages of CCl4 (0.05, 0.20, 0.40, and
0.80 mL/kg) to induce hepatotoxicity. Results showed that
SGOT and SGPT activities were increased by increasing the
concentrations of CCl4 as shown in Figure 1. A significant
difference in SGOT and SGPT activities between untreated
rats and the rats treated with silymarin was observed at low
dosages (0.05 and 0.20 mL/kg) of CCl4 induction. However,
when treated with higher dosages (0.40 and 0.80 mL/kg) of
CCl4 there was no significant difference observed between
these two groups.
III. Effect of Silymarin, Ganoderma lucidum, and Red
Ginseng Concentrate on Hepatotoxicity Induced by CCl4 at
Low Dosages
Rats were treated with silymarin, Ganoderma lucidum,
or red ginseng concentrate (the dosages of which refer to the
description in Materials and Methods) prior to intraperitoneal
administration with CCl4 at 0.05 and 0.20 mL/kg for 24 hr.
The SGOT and SGPT activities were significantly increased
for the rats treated with drugs concurrent with CCl4 administration as compared to vehicle control group, indicating CCl4
at lower dosages is still capable of inducing hepatotoxicity.
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Table 1. Effects of silymarin, Ganoderma lucidum and red ginseng on serum biochemical parameters, and body, liver, kidney weight in rats
Untreated
Silymarin
Ganoderma lucidum
Red ginseng
7 days
30 days
7 days
30 days
7 days
30 days
7 days
30 days
Body weight (g)
216.9 ± 3.7 350.5 ± 13.2 213.2 ± 5.2
365.8 ± 20.3 216.3 ± 3.0 342.2 ± 16.7 221.5 ± 4.6 344.1 ± 14.6
Liver/Body weight (%)
5.35 ± 0.18 4.11 ± 0.20 4.69 ± 0.19
4.13 ± 0.33
5.18 ± 0.14 4.06 ± 0.15 5.24 ± 0.23 3.89 ± 0.49
Kidney/Body weight (%) 0.83 ± 0.05 0.80 ± 0.20 0.80 ± 0.05
0.79 ± 0.25
0.83 ± 0.05 0.80 ± 0.20 0.86 ± 0.09 5.35 ± 0.18
SGOT (U/L)
118 ± 25
136 ± 7
123 ± 21
125 ± 11
119 ± 19
130 ± 13
130 ± 30
116 ± 5
SGPT (U/L)
48 ± 5
42 ± 4
52 ± 7
49 ± 6
43 ± 5
57 ± 8
54 ± 10
54 ± 6
ALP (U/L)
496 ± 104
407 ± 26
514 ± 87
550 ± 43
523 ± 46
510 ± 39
476 ± 48
523 ± 38
LDH (U/L)
915 ± 245
719 ± 64
897 ± 220
856 ± 55
880 ± 129
897 ± 34
921 ± 164 713 ± 27
BUN (U/L)
19.7 ± 2.7
19.7 ± 2.7
17.6 ± 1.6
17.9 ± 1.6
18.7 ± 2.1
20.4 ± 3.1
16.8 ± 2.3 18.3 ± 2.0
Rats were treated with silymarin, Ganoderma lucidum and red ginseng for 7 and 30 days according to the procedures outlined in “Materials and
Methods”.The data were expressed as mean ± s.e.m. (n>5) and analyzed with the student’s t-test.A p value of 0.05 or less is considered statistically significant.
Table 2. Effect of silymarin, Ganoderma lucidum and red ginseng administration on SGOT and SGPT activities in rats treated with low dosage of
CCl4
serum enzyme
Untreated
Silymarin
Ganoderma lucidum
Red ginseng
activities (U/L)
Corn oil
CCl4
Corn oil
CCl4
Corn oil
CCl4
Corn oil
CCl4
SGOT
118 ± 25
328a ± 42
123 ± 21
221a,b ± 39
119 ± 19
198 a,b ± 17
130 ± 30
220a,b ± 37
SGPT
48 ± 5
170a ± 18
52 ± 7
90a,b ± 26
43 ± 5
90 a,b ± 12
54 ± 10
95a,b ± 16
Rats were treated with silymarin, Ganoderma lucidum and red ginseng, and then with 0.05 mL CCl4/Kg, BW according to the procedures states in
“Materials and Methods”. The data were expressed as mean ± s.e.m. (n>5) and analyzed with the student’s t-test. A p value of 0.05 or less is considered statistically significant.
a
comparing the CCl4 and corn oil treated of each group.
b
comparing the CCl4-treated rats of untreated and silymarin, Ganoderma lucidum and red ginseng treated group.

(B)

Serum GPT activity (U/L)

Serum GPT activity (U/L)

(A)

CCl4(mL/kg, body weight)

CCl4(mL/kg, body weight)

Figure 1. Effect of silymarin on CCl4-induced liver injury.The CCl4-induced liver injury were evaluated by the increase of SGOT (A) and SGPT
(B) activities in serum from treated animals according to the procedures stated in Methods.Various concentrations of CCl4 were injected i.p. to
induce liver injury after the animals were treated with vehicle (●) or silymarin (■).The data were expressed as mean ± s.e.m. (n = 5). A p value
of 0.05 or less is considered statistically significant, *p <0.05.

Moreover, SGOT and SGPT activities in both experiment
and positive control groups at low dose CCl4 exposure were
significantly decreased as compared to the normal control
group (Table 2 and 3).
IV. Effect of Red Ginseng Concentrate on Hepatotoxicity
Induced by High Dosages of CCl4
The hepatotoxicity in rats was induced by CCl4 at 0.8

mL/kg for 24 hr and blood from the peritoneal artery was
tested for serum biochemistry. As shown in Table 4, the
SGOT and SGPT activities were significantly increased for
rats treated with CCl4 as compared to those treated with corn
oil, indicating hepatotoxicity was successfully induced by
CCl4. However, at such a high dosage of CCl4 induction, the
serum enzyme activities in rats treated with red ginseng concentrate (experiment group) showed no difference to those
rats treated with water (normal control group).
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Table 3. Effect of silymarin, Ganoderma lucidum and red ginseng administration on SGOT and SGPT activities in rats treated with medium dosage
of CCl4
serum enzyme
Untreated
Silymarin
Ganoderma lucidum
Red ginseng
activities (U/L)
Corn oil
CCl4
Corn oil
CCl4
Corn oil
CCl4
Corn oil
CCl4
SGOT
118 ± 25
670a ± 95
123 ± 21
452a,b ± 43
119 ± 19
497a,b ± 62
130 ± 30
481a,b ± 51
SGPT
48 ± 5
535a ± 123
52 ± 7
217a,b ± 40
43 ± 5
253a,b ± 28
54 ± 10
240a,b ± 33
Rats were treated silymarin, Ganoderma lucidum and red ginseng and then with 0.20 mL CCl4/Kg, BW according to the procedures states in
“Materials and Methods”. The data were expressed as mean ± s.e.m. (n>5) and analyzed with the student’s t-test. A p value of 0.05 or less is considered statistically significant.
a
comparing the CCl4 and corn oil treated of each group.
b
comparing the CCl4-treated rats of untreated and silymarin, Ganoderma lucidum and red ginseng treated group.
Table 4. Effect of red ginseng administration on SGOT and SGPT activities in rats treated with high dosage of CCl4
serum enzyme activities (U/L)
Untreated
Red ginseng
Corn oil
CCl4
Corn oil
CCl4
SGOT
157 ± 18.6
7098 ± 3117a
197 ± 42
7330 ± 125a
SGPT
57 ± 9
4400 ± 1253a
60 ± 5
3297 ± 990a
Rats were treated with red ginseng and then with 0.80 mL CCl4/ Kg, BW according to the procedures states in “Materials and Methods”. The data
were expressed as mean ± s.e.m. (n>5) and analyzed with the Student’s t-test. A p value of 0.05 or less is considered statistically significant.
a
comparing the CCl4 and corn oil treated of each group.

DISCUSSION
Health foods have become a part of daily life as people
have become aware of their benefits. However, health food
management and researchers have not been able to keep pace
with this growing market. The purpose of this study was to
establish a method to evaluate the CCl4-induced hepatotoxicity reduction ability (an index for hepato-protection) of
health foods. Silymarin was used as a positive control in this
study because it has been reported to clinically cure various
hepatic diseases(22-24). These include acute and chronic hepatitis caused by viruses, hepatic disease induced by alcohol, and
hepatitis and liver necrosis caused by drugs or toxicants.
Silymarin has been shown to have the ability to prevent CCl4induced liver cirrhosis (25) and to reduce CCl 4 -induced
SGPT(26,27). However, at high dosages (0.40 and 0.80 mL/kg)
of CCl4 induction, SGOT and SGPT were greatly increased
in both positive and normal control groups, but showing no
significant different between these two groups. This result
indicates a test model using a high dosage of CCl4 is not suitable for evaluation of hepato-protection drugs.
As mentioned above, the positive control group showed
no difference from the normal control group in SGOT and
SGPT activities induced by high-dose CCl4. The same result
was observed between the experimental group treated with
red ginseng concentrate, and the normal control group. This
could be due to a high-dose CCl4 exposure which can cause
severe liver damage and is hardly recovered by the hepatoprotection drug. Moreover, a high standard deviation was
observed in SGOT and SGPT at high-dose CCl4 exposure.
This could result in a variation in the evaluation of the liver
protective functionality of health foods. The health food
claimed for hepato-protection functionality should not be
overly expected to cure hepatic disease, since it is not a drug.
An experimental model using a high-dose CCl4 induction
could cause severe liver damage that could be hardly recovered by drugs, and therefore this model is not suggested to

evaluate the hepato-protection functionality of health food.
Gnaoderma lucidum and red ginseng as well as silymarin exhibit the ability to reduce hepatotoxicity, in terms of
SGOT and SGPT activities, induced by low-dose CCl4 (0.05
and 0.20 mL/kg). This result shows an experimental model
using a low-dose CCl4 exposure is not only able to induce
hepatotoxicity but also able to successfully evaluate the
hepato-protection ability of health food. SGOT and SGPT
are the two index enzymes for evaluation of hepato-protection functionality because they are abundant in liver and their
concentrations change significantly as liver injury occurs.
ALP and LDH are another two enzymes in liver in large
amounts. Clinically, ALP could be well expressed in the
patient with bile duct and bone diseases(30), while trace plasma excretion could increase LDH concentration in serums(31).
In this study, we have found that these two enzymes are not
suitable for evaluating hepato-protection functionality.
In Taiwan, silymarin has been approved as an adjuvant
for treatment of chronic hepatitis, liver cirrhosis, and fatty
liver. In this study, we have demonstrated that silymarin is
capable of significantly reducing SGOT and SGPT activities.
However, as compared to the vehicle group, which is treated
with corn oil only, silymarin could not entirely recover the
CCl4-induced hepatotoxicity by reducing SGOT and SGPT
activities to normal levels. Therefore, the positive control
group should be used as a reference to compare the CCl4induced SGOT and SGPT activities between experimental
and normal control groups. Based on our study, we have concluded that CCl4 is a good hepatotoxicity inducer. A model
using a low-dose CCl4 induction and by monitoring the
SGOT and SGPT activities in serum could effectively evaluate the hepato-protection functionality of health food.
However, we must stress that the CCl4-induced model could
only be applied to the evaluation of the protective effect on
liver injuries caused by drugs or toxicants, but not on chronic liver disease caused by viruses. The virus infection model
needs to perform an animal test in which gorillas are used as
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a subject.
The study on the toxic effect of long-term administration of health foods on organs (especially liver) showed no
pathological changes in the liver, kidney, pancreas, or spleen
(data not shown). The body, liver, and kidney weights, and
serum biochemical parameters were not significantly
changed. These results indicate that there is no adverse effect
on liver after a long-term administration of silymarin,
Ganoderma lucidum, and red ginseng concentrate.
The research on safety evaluation of health food is of
great importance. The need for a proper safety standard is an
international consensus. This safety standard should be
established on the basis of scientific data in which safety
dosage information is obtained via a toxicological test.
Nevertheless, some questions still remain to be solved in the
evaluation of the functionality of health food. It is agreed by
most countries that health food should not be claimed for curing purposes but only for strengthening health, such as promoting liver function, preventing liver injury, improving
digestion and absorption, promoting growth, adjusting blood
lipid composition, and reducing blood sugar. The evaluation
method established in this study could be a reference method
to evaluate health foods which claim for hepato-protection
functions. Moreover, other health food with a specific function should also be scientifically validated and approved by
related authorities prior to marketing approval. Thus, the
health-promoting functionality of commercially available
health food would be guaranteed.
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摘

要

對於保健食品作一適當的管理與規範是世界各國政府的共識，本研究目的是將針對宣稱具保肝功效的保
健食品，在陽性對照組-水飛薊的相較下，建立一套以四氯化碳誘導其肝毒性來評估保健食品的保肝功效。
本研究方法是以大白鼠做為實驗動物，著重於保護肝臟作用檢驗方法（每天 1 次，連續餵食 7 天，並以四氯
化碳誘導其肝臟毒性）與保健食品對肝臟慢性毒理之評估（每天 1 次，連續餵食 30 天），以了解相關的評估
方法是否確能驗證保健食品的機能性及安全性。在保護肝臟作用檢驗方法之評估方面，以低劑量四氯化碳
0.05 及 0.20 mL/大鼠體重（公斤）誘導下，對照組（水）動物血清酵素之 SGOT 值由 118± 25 分別上升至
328 ± 42 及 670 ± 95 (U/L)， SGPT 值由 48 ± 5 分別上升至 170 ± 18 及 535 ± 123 (U/L)；陽性對照組－餵
食水飛薊 140 mg/大鼠體重（公斤）之 SGOT 值由 123 ± 21 分別上升至 221 ± 39 及 452 ± 43 (U/L)， SGPT 值
由 52 ± 7 分別上升至 90 ± 26 及 217 ± 40 (U/L)。對照組與陽性對照組在此兩種四氯化碳濃度的誘導下，
其血清酵素中 SGOT 及 SGPT 值的上升程度皆有統計上的差異，由此結果顯示，水飛薊確實有保護肝臟並減輕
其受四氯化碳之傷害。再者，以靈芝及紅參精試驗之，其結果也都顯示具保護肝臟之作用。在保健食品對肝
臟之慢性毒理評估方面，經長期餵予動物保健食品後，分析其血清酵素之結果，我們發現在本研究中所使用
的劑量下，水飛薊、靈芝及紅參精並不會造成實驗動物之肝毒性。本研究之成果將可以提供一個具有科學性
與客觀性的方法來評估保健食品之保肝功，以作為政府決策單位訂定法規及管理規範保健食品事宜之參考。
關鍵詞：水飛薊，靈芝，紅參精，機能性，安全性，肝毒性

